Clinical Trial Update: Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for orally administered recombinant human lactoferrin to prevent antibiotic-associated diarrhea in adults; the study status is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibiotic-associated Diarrhea

Drugs mentioned

• Recombinant human lactoferrin (recombinant human lactoferrin)

Snippet

Sponsor: Ventria Bioscience | Conditions: Diarrhea | Phase 3 | Status: UNKNOWN